Page last updated: 2024-09-02

1-hexadecyl-2-acetyl-glycero-3-phosphocholine and sodium salicylate

1-hexadecyl-2-acetyl-glycero-3-phosphocholine has been researched along with sodium salicylate in 2 studies

Compound Research Comparison

Studies
(1-hexadecyl-2-acetyl-glycero-3-phosphocholine)
Trials
(1-hexadecyl-2-acetyl-glycero-3-phosphocholine)
Recent Studies (post-2010)
(1-hexadecyl-2-acetyl-glycero-3-phosphocholine)
Studies
(sodium salicylate)
Trials
(sodium salicylate)
Recent Studies (post-2010) (sodium salicylate)
9,1561875522,03150171

Research

Studies (2)

TimeframeStudies, this research(%)All Research%
pre-19902 (100.00)18.7374
1990's0 (0.00)18.2507
2000's0 (0.00)29.6817
2010's0 (0.00)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Alessandri, C; Balsano, F; Ghiselli, A; Guzzo, A; Praticò, D; Violi, F1
Cordeiro, RS; Martins, MA; Silva, PM; Vargaftig, BB1

Other Studies

2 other study(ies) available for 1-hexadecyl-2-acetyl-glycero-3-phosphocholine and sodium salicylate

ArticleYear
Inhibition of cyclooxygenase-independent platelet aggregation by sodium salicylate.
    Thrombosis research, 1989, Jun-15, Volume: 54, Issue:6

    Topics: Adult; Aspirin; Epinephrine; Female; Humans; Male; Platelet Activating Factor; Platelet Aggregation Inhibitors; Prostaglandin-Endoperoxide Synthases; Sodium Salicylate; Thromboxane A2

1989
Salicylates inhibit PAF-acether-induced rat paw oedema when cyclooxygenase inhibitors are ineffective.
    Prostaglandins, 1986, Volume: 32, Issue:5

    Topics: Animals; Anti-Inflammatory Agents, Non-Steroidal; Arachidonate Lipoxygenases; Aspirin; Cyclooxygenase Inhibitors; Dexamethasone; Edema; Male; Platelet Activating Factor; Rats; Rats, Inbred Strains; Salicylates; Sodium Salicylate

1986